Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
14.25
+1.15 (8.78%)
Nov 3, 2026, 2:36 PM EST - Market open

Syndax Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
289.68172.3523.68--139.71
Revenue Growth
160.26%627.84%---9109.56%
Gross Profit
8.35-93.4-218.79-163.03-118.5139.71
Operating Income
-178.64-273.08-339.67-229.95-151.7626.22
Net Income
-209.48-285.42-318.76-209.36-149.3424.93
Earnings Per Share
-2.37-3.29-3.72-2.98-2.460.46
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
437.26413.69582.91577.58484.4446.83
Total Debt
589.42345.43345.741.641.1620.97
Net Cash (Debt)
-152.1668.25237.17575.95483.24425.86
Net Cash Growth
--71.22%-58.82%19.19%13.47%53.62%
Net Cash Per Share
-1.720.792.778.187.957.94

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-177.36-322.98-274.9-160.6-133.6829.13
Capital Expenditures
-0.1-0.19----0.13
Free Cash Flow
-177.46-323.17-274.9-160.6-133.6829
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
2.88%-54.19%---100.00%
Operating Margin
-61.67%-158.45%-1434.43%--18.77%
Pretax Margin
-72.32%-165.60%-1346.11%--17.84%
Profit Margin
-72.32%-165.60%-1346.11%--17.84%
FCF Margin
-61.26%-187.50%-1160.91%--20.76%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----47.49
P/FCF Ratio
-----40.81
PS Ratio
4.4510.6047.65--8.47